The human skin/chick chorioallantoic membrane model accurately predicts the potency of cosmetic allergens

Experimental Dermatology

Volumn 18, Issue 4, 2009, Pages 409-413

  Slodownik, Dan ^a   Grinberg, Igor ^b   Spira, Ram M ^c   Skornik, Yehuda ^d   Goldstein, Ronald S ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b BAR ILAN UNIVERSITY   (Israel)

^c SHAARE ZEDEK MEDICAL CENTER   (Israel)

^d TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Allergen testing; Contact allergy; Langerhans cells; Local lymph node assay; Xenografting

Indexed keywords

ALLERGEN; COSMETIC;

ALLERGY TEST; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL MIGRATION; CHICK; CHORIOALLANTOIS; CONTACT DERMATITIS; CONTROLLED STUDY; EPIDERMIS CELL; HUMAN; IMMUNE RESPONSE; INTERMETHOD COMPARISON; LANGERHANS CELL; LOCAL LYMPH NODE ASSAY; NONHUMAN; SKIN SENSITIZATION;

ALLERGENS; ANIMALS; CELL MOVEMENT; CHICK EMBRYO; CHORIOALLANTOIC MEMBRANE; COSMETICS; DERMATITIS, ALLERGIC CONTACT; HUMANS; LANGERHANS CELLS; MODELS, ANIMAL; MODELS, BIOLOGICAL; PREDICTIVE VALUE OF TESTS; SKIN; SKIN TESTS; TRANSPLANTS;

EID: 63149180936     PISSN: 09066705     EISSN: 16000625     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2008.00803.x     Document Type: Article

References (30)

1. Ortiz K J, Yiannias J A. Contact dermatitis to cosmetics, fragrances, and botanicals. Dermatol Ther 2004: 17: 264-271.
2. Johansen J, Menne T, Christophersen J, Kaaber K, Veien N. Changes in the pattern of sensitization to common contact allergens in denmark between 1985-86 and 1997-98, with a special view to the effect of preventive strategies. Br J Dermatol 2000: 142: 490-495.
3. Lim J T, Goh C L, Ng S K, Wong W K. Changing trends in the epidemiology of contact dermatitis in Singapore. Contact Derm. 1992: 26: 321-326.
4. Lunder T, Kansky A. Increase in contact allergy to fragrances: patch-test results 1989-1998. Contact Derm. 2000: 43: 107-109.
5. Larsen W G. Detection of allergic dermatitis to fragrances. Acta Derm Venereol Suppl (Stockh) 1987: 134: 83-86.
6. Marks J G, Belsito D V, DeLeo V A et al. North American Contact Dermatitis Group patch test results for the detection of delayed-type hypersensitivity to topical allergens. J Am Acad Dermatol 1998: 38: 911-918.
7. Marks J G Jr, Belsito D V, DeLeo V A et al. North American Contact Dermatitis Group patch-test results, 1996-1998. Arch Dermatol 2000: 136: 272-273.
8. Trattner A, Farchi Y, David M. Cosmetics patch tests: First report from Israel. Contact Derm 2002: 47: 180-181.
9. Basketter D A, Evans P, Gerberick G F, Kimber I A. Factors affecting thresholds in allergic contact dermatitis: Safety and regulatory considerations. Contact Derm 2002: 47: 1-6.
10. Kimber I, Dearman R J, Basketter D A, Ryan C A, Gerberick G F. The local lymph node assay: Past, present and future. Contact Derm 2002: 47: 315-328.
11. Kimber I, Basketter D A, Butler M et al. Classification of contact allergens according to potency: Proposals. Food Chem Toxicol 2003: 41: 1799-1809.
12. Ryan C A, Chaney J G, Kern P S et al. The reduced local lymph node assay: The impact of group size. J Appl Toxicol 2008: 28: 518-523.
13. Takeyoshi M, Noda S, Yamasaki K, Kimber I. Advantage of using CBA/N strain mice in a non-radioisotopic modification of the local lymph node assay. J Appl Toxicol 2006: 26: 5-9.
14. Pistoor F H, Rambukkana A, Kroezen M et al. Novel predictive assay for contact allergens using human skin explant cultures. Am J Pathol 1996: 149: 337-343.
15. Rambukkana A, Pistoor F H, Bos J D, Kapsenberg M L, Das P K. Effects of contact allergens on human Langerhans cells in skin organ culture: migration, modulation of cell surface molecules, and early expression of interleukin-1 beta protein. Lab Invest 1996: 74: 422-436.
16. Lehe C L, Jacobs J J, Elliott G R, Das P K. A two-centre evaluation of the human organotypic skin explant culture model for screening contact allergens. Altern Lab Anim 2003: 31: 553-561.
17. Kaufmann R Mielke V, Reimann J, Klein C E, Sterry W. Cellular and molecular composition of human skin in long-term xenografts on SCID mice. Exp Dermatol 1993: 2: 209-216.
18. Nickoloff B J, Kunkel S L, Burdick M, Strieter R M. Severe combined immunodeficiency mouse and human psoriatic skin chimeras Validation of a new animal model. Am J Pathol 1995: 146: 580-588.
19. Goodpasture E W. A study of human skin grafted upon the chorioallantois of chick embryos. J Exp Med 1938: 68: 891-904.
20. Kunzi-Rapp K, Ruck A, Kaufmann R. Characterization of the chick chorioallantoic membrane model as a short-term in vivo system for human skin. Arch Dermatol Res 1999: 291: 290-295.
21. Frankenburg S, Grinberg I, Bazak Z et al. Immunological activation following transcutaneous delivery of HR-gp100 protein. Vaccine 2007: 25: 4564-4570.
22. Ryan C A, Cruse L W, Skinner R A, Dearman R J, Kimber I, Gerberick G F. Examination of a vehicle for use with water soluble materials in the murine local lymph node assay. Food Chem Toxicol 2002: 40: 1719-1725.
23. Jacobs J J, Lehe C, Cammans K D, Yoneda K, Das P K, Elliott G R. An automated method for the quantification of immunostained human Langerhans cells. J Immunol Methods 2001: 247: 73-82.
24. Cumberbatch M, Dearman R J, Griffiths C E, Kimber I. Langerhans cell migration. Clin Exp Dermatol 2000: 25: 413-418.
25. Scheinman P L. Prevalence of fragrance allergy. Dermatology 2002: 205: 98-102.
26. Weinlich G, Heine M, Stossel H et al. Entry into afferent lymphatics and maturation in situ of migrating murine cutaneous dendritic cells. J Invest Dermatol 1998: 110: 441-448.
27. Dearman R J, Hilton J, Evans P, Harvey P, Basketter D A, Kimber I. Temporal stability of local lymph node assay responses to hexyl cinnamic aldehyde. J Appl Toxicol 1998: 18: 281-284.
28. Warbrick E V, Dearman R J, Lea L J, Basketter D A, Kimber I. Local lymph node assay responses to paraphenylenediamine: Intra- and inter-laboratory evaluations. J Appl Toxicol 1999: 19: 255-260.
29. Kimber I, Basketter D A, Berthold K et al. Skin sensitization testing in potency and risk assessment. Toxicol Sci 2001: 59: 198-208.
30. Goyarts E, Matsui M, Mammone T et al. Norepinephrine modulates human dendritic cell activation by altering cytokine release. Exp Dermatol 2008: 17: 188-196.